Posts from the Newsroom

Rallybio Completes $37.0M Series A Financing

Rallybio Completes $37.0M Series A Financing

Rallybio Established by Industry Leaders with $37.0 Million in Series A Financing to Develop Transformative Therapies for Patients with Severe and Rare Diseases FARMINGTON, CT, April 25, 2018 – Rallybio, LLC, a biotechnology company established to identify and...

read more
Connecticut Bioscience Advocacy 2018

Connecticut Bioscience Advocacy 2018

Rallybio will be attending Connecticut Bioscience Advocacy 2018 on Thursday, March 15th, at the Capitol in Hartford.  The conference is being hosted by BioCT and will focus on the importance of bioscience to our state’s economy and future biosciences crossroads. For...

read more

Why We Do What We Do

It's hard not to become emotional when the patients we meet share their stories.  Evie is just one of those patients we've met who's touched our heart and motivates us to do what we do. Check out a video of Evie's Story produced by Charles River that features Rallybio...

read more

CT Rare Disease Day

The Rallybio team will be attending the 2018 Connecticut Rare Disease Day Advocacy Event in Hartford on Wednesday, February 28th. The purpose of this event is to raise awareness here in Connecticut for the 1 in 10 individuals living with a rare disease and the...

read more